News & Events
In this free webinar hosted by TTC, attendees will learn about a new adjuvanted subunit mucosal Covid-19 vaccine that incorporates a unique nanoparticle formulation. In vivo study results demonstrated that it can protect against respiratory SARS-CoV-2 exposure and may enhance the protective effect of systemic vaccines. This makes it a good candidate for a SARS-CoV-2 vaccine. Attend the webinar to hear from the NCI inventor and learn more about the technology which is available for collaboration and licensing.March 13, 2024 | 11:00 AM – 12:00 PM
This webinar was originally scheduled for January 31, but is now rescheduled for May 22.
Attendees will learn about a potential, novel treatment for Retinitis Pigmentosa (RP). Over 100,000 in the U.S. and 1.5 million people worldwide suffer from RP, which leads to progressive photoreceptor cell degeneration and ultimately vision loss. A new therapeutic technology from the National Eye Institute has the potential to be a treatment option for RP patients and may also protect retinal cells from damage associated with glaucoma and age-related macular degeneration (AMD). Attend the webinar to assess the technology for partnership and licensing opportunities.May 22, 2024 | 11:00 AM – 12:00 PM